Evolving Clinical Supply Chains to Advance ADC Innovation from Discovery to Development & Beyond

• Assessing supply chain and process development strategy to enable ADC discovery innovation to flow through to first-in-human clinical trials
• Navigating the complexities of ADCs: Linker-payload chemistry, mAb, conjugation, sterile fill and finish in the design of future clinical supply chains
• Understanding key elements to ensure successful process scale up and transfer of ADC across the end-to-end supply chain

Speakers:

Luisa Freitas dos Santos

Vice President - Global Clinical Supply Chain

GSK